Publications by authors named "Manu Pandey"

Claim this Profile
T
The role of interim bone marrow assessments in acute myeloid leukemia - A systematic review and meta-analysis.
Yuanli Lei, Zhiting Tang, Jessica A Reese, Omer Jamy, Mohamad Khawandanah, Manu Pandey

Leuk Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing Natural Killer Cellular Therapy in Acute Myeloid Leukemia.
Binsah George, Manu Pandey, Jacob Herstein, Abhishek Maiti

Am J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Bottom Line: Donor Age Over HLA Mis-Match? Picking a Mismatched Donor in the Era of Post-Transplant Cyclophosphamide.
Manu R Pandey, Jennifer Holter-Chakrabarty

Transplant Cell Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physician Advocacy for Hematopoietic Cell Transplantation and Cell Therapy: Overcoming Challenges to Reduce Disparities and Improve Outcomes for Patients.
Nima Ghalehsari, Manu Pandey, Jeffery J Auletta, Ellie Beaver, Stella M Davies

Transplant Cell Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding Diversity: An ASTCT-NMDP ACCESS Initiative Survey of the Hematopoietic Cell Transplant and Cellular Therapy Workforce in the United States.
Maria A Pereda Ginocchio, Kristie N Ramos, Manuel R Espinoza-Gutarra, Nima Ghalehsari, Manu Pandey

Transplant Cell Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular disease-related mortality trends among adults with multiple myeloma in the United States from 1999 to 2023.
Usama Qamar, Siddharth Agarwal, Mohamad Khawandanah, Manu Pandey, Taha AlJuhaishi

Leuk Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
F-FLT PET and Blood-based Biomarkers for Identifying Gastrointestinal Graft versus Host Disease after Allogeneic Cell Transplantation.
Jennifer Holter-Chakrabarty, Lacey McNally, John Levine, James Ferrara, Sara K Vesely, Manu Pandey

Radiol Imaging Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in Jehovah's witness patients.
Jeffrey Baron, Manu R Pandey, Elizabeth A Griffiths, Eunice S Wang

Leuk Res Rep· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloid-derived suppressor cell mitochondrial fitness governs chemotherapeutic efficacy in hematologic malignancies.
Saeed Daneshmandi, Jee Eun Choi, Qi Yan, Cameron R MacDonald, Manu Pandey

Nat Commun· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of primary organ site of involvement by peripheral T-cell lymphoma not otherwise specified on survival.
Olivia Davis, Derek Truong, Silas Day, Manu Pandey, Sami Ibrahimi

Cancer Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Race and Age and their Interaction on Survival Outcomes in Patients With Diffuse Large B-Cell Lymphoma.
Kira MacDougall, Silas Day, Spencer Hall, Daniel Zhao, Manu Pandey

Clin Lymphoma Myeloma Leuk· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy.
Jurjen Versluis, Manu Pandey, Yael Flamand, J Erika Haydu, Roger Belizaire

Blood Adv· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter evaluation of efficacy and toxicity of venetoclax-based combinations in patients with accelerated and blast phase myeloproliferative neoplasms.
Amber C King, Taylor M Weis, Andriy Derkach, Somedeb Ball, Manu Pandey

Am J Hematol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The side effects of immune checkpoint inhibitor therapy on the endocrine system.
Itivrita Goyal, Manu Raj Pandey, Rajeev Sharma, Ajay Chaudhuri, Paresh Dandona

Indian J Med Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing thermal stress reduction strategies that influence MDSC accumulation in tumor bearing mice.
Cameron MacDonald, Samuel Ministero, Manu Pandey, Denisha Robinson, Evan Forti Hong

Cell Immunol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity.
Shipra Gandhi, Manu R Pandey, Kristopher Attwood, Wenyan Ji, Agnieszka K Witkiewicz

Clin Cancer Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism-based treatment of cancer with immune checkpoint inhibitor therapies.
Yara Abdou, Manu Pandey, Maithreyi Sarma, Shrunjal Shah, Jeffrey Baron

Br J Clin Pharmacol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HYPOTHYROIDISM AND GOITER IN A YOUNG MALE WITH SUSPECTED DIETARY IODINE DEFICIENCY FOLLOWED BY THYROTOXICOSIS AFTER IODINE SUPPLEMENTATION.
Itivrita Goyal, Manu Raj Pandey, Rajeev Sharma

AACE Clin Case Rep· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diffuse large B-Cell lymphoma associated with paraneoplastic Guillain-Barré syndrome: A diagnostic and therapeutic challenge.
Brototo Deb, Manu R Pandey, Pallawi Torka, Suchitra Sundaram

Hematol Oncol Stem Cell Ther· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of concomitant medication use and immune-related adverse events on response to immune checkpoint inhibitors.
Shipra Gandhi, Manu Pandey, Nischala Ammannagari, Chong Wang, Mark J Bucsek

Immunotherapy· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What potential is there for LSD1 inhibitors to reach approval for AML?
Manu R Pandey, Eunice S Wang

Expert Opin Emerg Drugs· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism of resistance to immune checkpoint inhibitors.
Manu R Pandey, Marc S Ernstoff

Cancer Drug Resist· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic sarcomatoid renal cell carcinoma treated with immune checkpoint inhibitors.
Ahmad Hanif, Manu Pandey, Sumera Khan, Kristopher Attwood, Saby George

Oncoimmunology· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heart Failure: A Paraneoplastic Manifestation of Renal Cell Carcinoma - Reversed With Pazopanib.
Manu Pandey, Shipra Gandhi, Saby George

Clin Genitourin Cancer· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges faced when identifying patients for combination immunotherapy.
Marc S Ernstoff, Shipra Gandhi, Manu Pandey, Igor Puzanov, Petros Grivas

Future Oncol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis